Viral vaccine manufacturing
Executive Summary
Vaccines and Related Biological Products Advisory Committee will discuss adventitious testing, tumorigenicity testing, and issues related to residual cell substrate DNA in viral vaccine manufacturing during May 16 meeting. The meeting will begin at 8 a.m. at the Holiday Inn in Gaithersburg, Md